2023
Safe Opioid Prescribing and Controlled Substance Policies
Tobin D, Barrette E. Safe Opioid Prescribing and Controlled Substance Policies. 2023, 233-254. DOI: 10.1007/978-3-031-40273-9_16.Peer-Reviewed Original ResearchOpioid prescribingPrimary care physiciansResident continuity clinicProperties of opioidsContinuity clinicCare physiciansRisk of overdoseClinical directorsOpioidIndividual patientsPotential harmAdverse effectsPrescribingPatientsClinicPotential benefitsRegulatory landscapeRiskPotential riskAnalgesicPhysicians
2021
Opioids for chronic pain management in patients with dialysis-dependent kidney failure
Tobin DG, Lockwood MB, Kimmel PL, Dember LM, Eneanya ND, Jhamb M, Nolin TD, Becker WC, Fischer MJ. Opioids for chronic pain management in patients with dialysis-dependent kidney failure. Nature Reviews Nephrology 2021, 18: 113-128. PMID: 34621058, PMCID: PMC8792317, DOI: 10.1038/s41581-021-00484-6.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPain managementChronic painOpioid therapyKidney failureDialysis-dependent kidney failureLong-term opioid therapyHealth care resource useGuideline-recommended careOpioid Prescribing PatternsHalf of patientsChronic pain managementBurden of painEffectiveness of opioidsUnique pharmacological propertiesAnalgesic optionsPrescribing patternsAdult patientsMost patientsSevere painMaintenance haemodialysisOpioid analgesicsPainGeneral populationPatientsHaemodialysis
2018
Pharmacotherapy for Alcohol Use Disorder
Holt SR, Tobin DG. Pharmacotherapy for Alcohol Use Disorder. Medical Clinics Of North America 2018, 102: 653-666. PMID: 29933821, DOI: 10.1016/j.mcna.2018.02.008.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAlcohol use disorderUse disordersNondrug therapiesUndertreated diseaseTreatment optionsPharmacotherapeutic agentsDrug interactionsTreatment goalsUS FoodDrug AdministrationSpecific patientDrug availabilityDisordersPatientsCounseling strategiesComorbiditiesMedicationsPharmacotherapyOptionsTherapyDiseaseAdministrationCare
2017
Safe Opioid Prescribing and Controlled Substance Policies
Tobin D, Barrette E. Safe Opioid Prescribing and Controlled Substance Policies. 2017, 157-180. DOI: 10.1007/978-3-319-68267-9_14.Chapters
2016
Breaking the pain contract: A better controlled-substance agreement for patients on chronic opioid therapy
Tobin DG, Keough Forte K, Johnson McGee S. Breaking the pain contract: A better controlled-substance agreement for patients on chronic opioid therapy. Cleveland Clinic Journal Of Medicine 2016, 83: 827-835. PMID: 27824537, DOI: 10.3949/ccjm.83a.15172.Peer-Reviewed Original ResearchPrescribing opioids in primary care: Safely starting, monitoring, and stopping
Tobin DG, Andrews R, Becker WC. Prescribing opioids in primary care: Safely starting, monitoring, and stopping. Cleveland Clinic Journal Of Medicine 2016, 83: 207-215. PMID: 26974992, DOI: 10.3949/ccjm.83a.15034.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsChronic opioid therapyChronic noncancer painPrimary care providersPrescription drug abuseNoncancer painOpioid therapyOpioid misusePrimary careCare teamCare providersEpidemic proportionsMeaningful benefitPatient communicationOpioidsDrug abuseAdverse effectsAbusePainOutpatientsPatientsTherapyCare
2004
Full-Body Skin Examinations: The Patient's Perspective
Federman DG, Kravetz JD, Tobin DG, Ma F, Kirsner RS. Full-Body Skin Examinations: The Patient's Perspective. JAMA Dermatology 2004, 140: 530-534. PMID: 15148096, DOI: 10.1001/archderm.140.5.530.Peer-Reviewed Original ResearchConceptsPrimary care practitionersSkin cancerRisk factorsWest Haven Veterans Affairs Medical CenterVeterans Affairs Medical CenterPatient risk factorsPercent of participantsPatient questionnaireClinic appointmentsCutaneous malignanciesDermatology clinicExamination ratePrimary careLower incidencePatient reportsMedical CenterPatient's perspectiveCare practitionersCancer altersPatientsScreening testCancerConvenience samplePersonal historyLower rates